Nusantics
Indonesian genotech firm Nusantics secures funding for new Covid-19 test kit tech
Nusantics is planning to use the fund to continue expanding its research and development in the field of genomes of different microorganisms. Aside from microbiome analysis, Nusantics also plans to delve into research and production geared towards medical diagnostic kits, specifically Covid-19.
January 8, 2021
Fujitsu and Paradigm test AI screening for Japan trials
November 20, 2026
MetaComp adds about $10M from Tether and Further
November 20, 2026
Fujitsu and Paradigm test AI screening for Japan trials
November 20, 2026
MetaComp adds about $10M from Tether and Further
November 20, 2026




